Progress in the Application

Slides:



Advertisements
Similar presentations
Heavy Ion Cancer Therapy
Advertisements

Experience, Expertise and a Commitment to Excellence™
Accelerators. Electron Beam  An electron beam can be accelerated by an electric field. Monitors Mass spectrometers  Any charged particle can be accelerated.
Carbon ion fragmentation study for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck base, prostate)
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Design and test of a high-speed beam monitor for hardon therapy H. Pernegger on behalf of Erich Griesmayer Fachhochschule Wr. Neustadt/Fotec Austria (H.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme PAMELA: Concepts Particle Accelerator for MEdicaL Applications K.Peach(JAI,
Solenoid-Based Focusing Lens for a Superconducting RF Proton Linac Presentation prepared for AEM 11/08/20101I. Terechkine.
Heavy Ion Tumor Therapy
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
The Skandion clinic, plans for the use of particle beams for radiation therapy in Sweden presented by Erik Grusell, medical radiation physicist Dept of.
FFAG Fixed Field Alternating Gradient synchrotrons, FFAGs, combine some of the main advantages of both cyclotrons and synchrotrons:  Fixed magnetic field.
FFAG Tune-stabilized, Linear-field Nonscaling FFAG Lattice Design C. Johnstone, Fermilab S. Koscielniak, TRIUMF FFAG07 April 12-17, 2007 LPSC, Grenoble,
A Laser Afternoon: Introduction Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin.
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
An Introduction To Particle Accelerators A-Level Physics.
The Magic Cube and the Pixel Ionization Chamber: detectors for monitor and dosimetry of radiotherapy beams S. Amerio 1, A. Boriano 2, F. Bourhaleb 2,3,
2002/7/02 College, London Muon Phase Rotation at PRISM FFAG Akira SATO Osaka University.
2002/7/04 College, London Beam Dynamics Studies of FFAG Akira SATO Osaka University.
The ISIS strong focusing synchrotron also at the Rutherford Appleton Laboratory. Note that ISIS occupies the same hall as NIMROD used to and re- uses some.
MedAustron Dr. Peter Urschütz, EBG MedAustron GmbH
ADSRs and FFAGs Roger Barlow. 7 Jan 2008Workshop on ADSRs and FFAGsSlide 2 The ADSR Accelerator Driven Subcritical Reactor Accelerator Protons ~1 GeV.
Cancer Therapy and Imaging Cancer Therapy and Imaging Rob Edgecock STFC Rutherford Appleton Laboratory.
Advanced Accelerator Design/Development Proton Accelerator Research and Development at RAL Shinji Machida ASTeC/STFC/RAL 24 March 2011.
CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.
Michael GalonskaWAO ´12, August Five years of operation at HIT Daily Performance Check & Beam Time Statistics M. Galonska, S. Scheloske, R. Cee,
FFAG Tune-stabilized, Linear-field FFAG C. Johnstone, Fermilab S. Koscielniak, TRIUMF FFAG06 Japan f Fermilab.
JAI-Diamond Joint Seminar 07/06/20071 Development of Non-Scaling FFAG : EMMA & PAMELA Takeichiro Yokoi J. Adams Institute Oxford University.
FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a wide variety of applications Cancer Therapy and UK Activities.
Part IV Applications. Prototype of Cancer therapy machine with proton 150 MeV FFAG as a prototype Commissioning to accelerate up to ~15 MeV is done. Tune.
New Gantry Idea for H + /C 6+ Therapy G H Rees, ASTeC, RAL 4 th September, 2008.
Dec 15, 2003 Protons for Cancer Therapy & Imaging Steve Peggs, BNL.
Polarized source upgrade RSC, January 11, OPPIS LINAC Booster AGS RHIC ( ) ∙10 11 p/bunch 0.6mA x 300us→11∙10 11 polarized H - /pulse. ( )
FrontierScience G.P.1 MATRIX an innovative Pixel Ionization Chamber for Online Monitoring of Hadrontherapy Treatments Giuseppe Pittà.
Odds and Ends on Gantries Rob Edgecock & Akram Kahn Neither of us knew much about gantries ~1 week ago Neither of us know much about gantries now Will.
T. Fleck, GSI, Darmstadt, Germany ICALEPCS Status of the Control System for HICAT at an advanced stage of Commissioning Functions, Restrictions.
Future Circular Collider Study Kickoff Meeting CERN ERL TEST FACILITY STAGES AND OPTICS 12–15 February 2014, University of Geneva Alessandra Valloni.
July PRISM Workshop,ICL Extraction in PAMELA, T.Yokoi Extraction in PAMELA Takeichiro Yokoi (JAI, Oxford University, UK)
Development of a superconducting rotating-gantry for carbon therapy
Hartmut Eickhoff, GSI 1 Developments in Hadrontherapy -the role of Basic Research Institutes H. Eickhoff GSI/Darmstadt.
Clinical Application of Carbon Therapy
Medical Applications 6 contributions on Particle therapy: Magnets for
ADSR Cockcroft ins., 10,July, 2009 Status of PAMELA, T.Yokoi Status of PAMELA Takeichiro Yokoi(JAI)
The Australian Hadron Therapy and Research Facility.
Introduction to NS-FFAGs and EMMA Rob Edgecock STFC Rutherford Appleton Laboratory.
Varian Medical Systems
Medical application of proton accelerators
Koichi MurakamiGeant4 Physics Verification and Validation (17-19/Jul./2006) 1 Results from the recent carbon test beam at HIMAC Koichi Murakami Statoru.
April 17, Dejan TrbojevicFFAG07 -Non-Scaling FFAG gantries1 Non-Scaling FFAG Gantries Introduction: Motives: The most challenging problem in the carbon/proton.
beam delivery with SC magnets
Page 1 WP10.2: TA DESY- II Test Beam Facility AIDA-2020 First Annual Meeting Norbert Meyners, Marcel Stanitzki, Natalia Potylitsina-Kube DESY.
WG3 closing summary Rob Apsimon (Tom Kroc, George Coutrakon)
MLL Workshop on Future Science 2019 and beyond, 16.Dec.2015 The accelerator, as seen by.. 1 From LBNL Image Library Collection by Dave Judd and Ronn MacKenzie.
Accelerator Physics Challenges in Radiotherapy Machines
Present and possible future schemes for hadron therapy linacs Alberto Degiovanni for the ADAM team HG2017 Workshop , Valencia.
Advanced Accelerator options ion beam therapy and research
Dr. C. Johnstone, Fermilab
Options and Recommendations for TL and Dumps
Injector Cyclotron for a Medical FFAG
Accelerator layout > 1000 components (almost 300 magnets and power converters, 153 beam diagnostic devices, about 400m of vacuum pipes, a not neglectable.
Johannes Leidner, Fabrizio Murtas, Marco Silari
Closeout of VHEE17 Workshop
Kuanjun Fan Institute of applied electromagnetic engineering
A Design of a Gantry with Superconducting Magnets for 350 MeV Protons
Design of a PET-isotope-based hadron therapy facility
M. D. Anderson Cancer Center Houston, TX
FFAG Accelerator Proton Driver for Neutrino Factory
A summary of world-wide test beam facilities
Non-invasive Beam Position Monitor Research in HUST-PTF
Innovations in the Radiotherapy of Non–Small Cell Lung Cancer
Presentation transcript:

Progress in the Application of Hadron Therapy (protons or ions) Marco Schippers

The boost in particle therapy more hospital based mostly in labs Loma Linda (Ca, USA) Particle therapy group: until 2015 > 150.000 patients treated www.ptcog.ch

Contents Introduction: particle therapy Accelerators Synchrotron Cyclotron Treatment facilities What is so special?

X-ray dose heart X-ray beams (IMRT ) from 7 directions X-rays lung Spinal cord

Dose profile of protons 2 4 6 8 10 12 14 16 18 Bragg peak Dose (a.u.) Depth in tissue (cm)

X-rays vs. Protons heart heart Proton beams X-ray beams (IMRT ) from 7 directions Proton beams from 3 directions X-rays Protons lung heart Spinal cord heart lung Spinal cord pictures: Medaustron

Biological effect of Carbon ions   RBE>1: Less dose for same cell killing RBE= 1.1 RBE≈ 3 electron track (or energy) density at nm scale effects RBE ( this means: RBE≠ 1 )

Pencil beam scanning kHz-Intensity modulation intensity 0 time (ms) 10 Spot scanning: step&shoot Continuous scanning 0 time (ms) 10 intensity kHz-Intensity modulation allows fast target repainting: 15-30 scans / 2 min.

Present accelerator choice 3.5 m e.g: Boston Florida Seoul Wanjie PSI München Orsay e.g.: Loma Linda Houston Tsukuba cyclotron synchrotron Protons in use, 3.5-5 m in use, 8-10 m Carbon ions in design, 6 m in use, 25 m

Proton source + injector Synchrotron Hitachi Ltd Extracted beam Protons only: ( ~8 m) synchrotron Proton source + injector synchrotron Ions (p-C): ( ~25 m) Heidelberg Extracted beam Injector Ion sources

Synchrotron beam structure in time Beam intensity Time  1-10 sec 0.5-1 sec in development “spill” time fill ring with ~1011 particles accelerate to desired energy extract slowly during 1-10 sec decelerate and dump unused particles

Cyclotron 230 MeV (IBA, SHI,1996) 250 MeV (ACCEL/Varian,2005) SC coils: diam 3.5 m, 100 tons 230 MeV (IBA, SHI,1996) iam. 5 m, 200 tons

E-adjustment with cyclotron 250 MeV cyclotron All following magnets: 1% field change in 50-80 ms At PSI: Graphite degrader 238-70 MeV

Small cyclotron Synchro-Cyclotron fRF 1 ms very strong magnetic field: B decreases with radius  Tcircle increases with radius. SO: decrease fRF with radius and extract Repeat 1000 x per sec time fRF 1 ms Each pulse: set intensity at source within ms (=> typ 10-30% accuracy) => Spot scanning requires >2 pulses per spot.

Synchro-Cyclotron 8-10 T 250 MeV Synchro-cyclotron on a gantry First system installed in 2013

Accelerator status (protons) cyclotron synchrotron small synchro- cyclotron linac Current Useability => Quality FFAG laser Dielectr. wall linac Plasma wake field Now Mañana Time until useable

Proton therapy: multi-room facility Cyclotron or synchrotron gantries At cyclotron: degrader+ energy selection beam transport IBA

Gantries 10-12 m IBA ~90 t Loma Linda (Optivus)

PSI Gantry-2: fast 3D scanning Eros Pedroni David Meer

Gantry for carbon-therapy HIT, Heidelberg

NEW: SC gantries NIRS, Japan SC dipoles Scanning XY Pronova, Knoxville, USA

PSI’s superconducting gantry design Collimators Degrader Scanning magnets Rotation axis Isocenter combined function, achromatic bending Degrader mounted on the gantry Momentum acceptance of approx. ±12.5 % Treatment of the small tumors without change of the SC magnet field

Acc.Lab  Hospital What is so special? Radiologist operates Operators Technicians Experienced workshops More improvised actions Radiologist operates CE/FDA-certification: PROCEDURES Local technicians:only small repairs Service by equipment company

Safety  Availability Patient safety: Machine interlocks: Separate interlock systems e.g. : Machine interlocks: all components technically OK More specially for treatments Area access & area dose: Doors closed, dose rate < µSv/h Patient safety: Dose delivery as planned

Patient safety interlock system Redundancy measurement BEAM off Alarm level stop Redundancy Redundancy Patient safety interlock system stop Alarm level

Operation: non-accelerator experts What has happened ? Strong need for ERGONOMIC display of: Status Instructions NO BEAM

Control and safety: What is so special? Accelerators for Medical Application What is so special? Technics: dedicated, but not on the limit of technology ….but… Reliable, Reproducible, Reliable, Reproducible Operation: by non-accelerator experts strictly according procedures Control and safety: VERY DEDICATED and SPECIAL : Reliable & Redundant, but not too sensitive

SUMMARY Dose: finite range maximum dose at end of track Apply the dose by Pencil Beam Scanning Accelerators for Medical Application: Cyclotron Synchrotron Medical applications: VERY Special Operation Facilities: Gantry aims the beam from all directions Recent development: SC magnets

Thank you !! …. Motivation …. first scanning gantry : PSI, 1996 Gantry: Eros Pedroni Tumours in kids: Beate Timmermann, Gudrun Goitein